New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run

from Journal of Clinical Oncology (JCO) Podcast

Reflections on a new report describing the successful therapy of lymphomas using adoptively transferred T cells targeting EBV latent membrane proteins.

Episode metadata supplied by the publisher feed · Published Dec 16, 2013

Embed this episode

Attribution link and audio player

NOW PLAYING

New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run

0:00 8:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 8 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on December 16, 2013.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!